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Anxiety is a psychological, physiological, and behavioral
state induced in animals and humans by a threat to well-
being or survival, either actual or potential. It is character-
ized by increased arousal, expectancy, autonomic and neu-
roendocrine activation, and specific behavior patterns. The
function of these changes is to facilitate coping with an
adverse or unexpected situation. Pathological anxiety inter-
feres with the ability to cope successfully with life chal-
lenges. Vulnerability to psychopathology appears to be a
consequence of predisposing factors (or traits), which result
from numerous gene–environment interactions during
development (particularly during the perinatal period) and
experience (life events). In this review, the biology of fear
and anxiety will be examined from systemic (brain–behav-
ior relationships, neuronal circuitry, and functional neu-
roanatomy) and cellular/molecular (neurotransmitters, hor-
mones, and other biochemical factors) points of view, with
particular reference to animal models. These models have
been instrumental in establishing the biological correlates
of fear and anxiety, although the recent development of
noninvasive investigation methods in humans, such as the
various neuroimaging techniques, certainly opens new
avenues of research in this field. Our current knowledge
of the biological bases of fear and anxiety is already
impressive, and further progress toward models or theo-
ries integrating contributions from the medical, biological,
and psychological sciences can be expected.
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n a book published in 1878 (Physiologie des
passions), Charles Letourneau, who was contemporary
with the French neuroanatomist Paul Broca, defined
emotions as “passions of a short duration”and described
a number of physiological signs and behavioral responses
associated with strong emotions.
1 Emotions are “inti-
mately linked with organic life,”he said,and either result
in an “abnormal excitation of the nervous network,”
which induces changes in heart rate and secretions, or
interrupt “the normal relationship between the periph-
eral nervous system and the brain.” Cerebral activity is
focused on the source of the emotion;voluntary muscles
may become paralyzed and sensory perceptions may be
altered, including the feeling of physical pain.This first
phase of the emotional response is followed by a reac-
tive phase,where muscles come back into action,but the
attention still remains highly focused on the emotional
situation.With the knowledge of brain physiology and
anatomy that was available at the end of the 19th cen-
tury,hypotheses on the mechanisms possibly involved in
emotions were of course limited.However,Letourneau
assumed that “the strong cerebral excitation” that
accompanies emotions probably only concerned “cer-
tain groups of conscious cells” in the brain and “must
necessitate a considerable increase of blood flow in the
cell regions involved.”
1 He also mentioned that the
intensity, the expression, and the pathological conse-
quences of emotions were directly linked to “tempera-
ments” (which he defined within the four classic
Hippocratic categories).
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IIt is amazing to see how Letourneau’s views on emotions,
more than a century ago,were in many ways premonitory.
The fact that emotions are “intimately linked with organic
life,”his precise description of the sequence of the physi-
ological and behavioral reactions that accompany a strong
emotion,such as fear,the idea that emotions involve spe-
cific areas of the brain,and the theory that activation of
these areas is associated with an increased blood flow
have all been largely confirmed by modern neuroscience.
The suggestion that temperament or personality traits
influence the “affective style”and vulnerability to psy-
chopathology is also an important aspect of our modern
approach to anxiety and mood disorders.
2
For a long time,emotions were considered to be unique
to human beings,and were studied mainly from a philo-
sophical perspective.
3 Evolutionary theories and progress
in brain and behavioral research, physiology, and psy-
chology have progressively introduced the study of emo-
tions into the field of biology, and understanding the
mechanisms, functions, and evolutionary significance 
of emotional processes is becoming a major goal of
modern neuroscience.
Three fundamental aspects of emotions
The modern era of emotion research probably started
when it became obvious that emotions are not just “feel-
ings” or mental states, but are accompanied by physio-
logical and behavioral changes that are an integral part
of them.This has progressively led to today’s view of
emotions being experienced or expressed at three dif-
ferent,but closely interrelated levels:the mental or psy-
chological level,the (neuro)physiological level,and the
behavioral level.These three complementary aspects are
present in even the most basic emotions,such as fear.
A detailed account of the many “theories of emotion”is
beyond the scope of this review. However, a brief his-
torical survey of the more biologically oriented ones
may help to set some important conceptual issues.
3-8
One of the main questions addressed by earlier scien-
tific theories of emotions was whether physiological
changes precede the emotional experience,or if they are
only a consequence of it. For James (1884) and Lange
(1885),“[…] the bodily changes follow directly the per-
ception of the existing fact, and […] our feelings of the
same changes as they occur IS the emotion.” In other
words, according to the James-Lange theory of emo-
tions, stimuli reaching the cerebral cortex induce vis-
ceral changes, which are then perceived as emotion.
Cannon and Bard (1915–1932) criticized this theory and
proposed that the neurophysiological aspects of emo-
tions are subcortical and involve the thalamus.
9 Stimuli
from the environment activate the thalamus,which relays
information to the cortex and viscera,and back again to
the cortex to generate the “emotional state.”Watson,the
father of behaviorism, was also very critical of what he
called the “introverted viewpoint”of James’ theory.He
considered that there were only three types of unlearned
emotional responses,which he called “fear,”“rage,”and
“love” for convenience, although he wanted to “[…]
strip them out of all their old connotations.”
10 These
three emotional responses can be elicited by three sets
of specific stimuli.Thus,a sudden noise or loss of physi-
cal support can induce an innate fear reaction, and
restraint of bodily movements triggers rage. He also
mentioned the fact that these emotional responses can
be conditioned and that, although these reactions are
usually accompanied by specific behaviors,“[…] vis-
ceral and glandular factors predominate.”Papez’s (1937)
theory of emotions also had a physiological basis. For
him,connections between the cerebral hemispheres and
the hypothalamus, and between the cerebral hemi-
spheres and the dorsal thalamus mediate emotions. He
held the view that emotion implies behavior (expression)
and feeling (experience,subjective aspects).Expression
depends on the hypothalamus, and experience on the
cortex.Although the “circuit of Papez”is still presented
as “the emotional brain” in some handbooks, it is clear
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Selected abbreviations and acronyms
ACTH adenocorticotropic hormone
BIS behavioral inhibition system 
BNST bed nucleus of the stria terminalis
CeA central nucleus of the amygdala
CRF corticotropin-releasing factor 
GABA γ-aminobutyric acid
HPA hypothalamo-pituitary-adrenocortical (axis)
5-HT 5-hydroxytryptamine (serotonin)
5-HTT serotonin transporter
LC locus ceruleus
NA noradrenaline
NTS nucleus tractus solitarius
PAG periaqueductal gray
PBR peripheral benzodiazepine receptor
PFC prefrontal cortex
PVN paraventricular nucleusthat many details of his original theory are now out-
dated.More recently,Schachter (1975) emphasized the
importance of cognitive processes: bodily states are
interpreted in a cognitive context and are modulated by
experience. He also showed that the visceral response
appears to be a necessary, although not sufficient, con-
dition for the occurrence of emotion.
The view that there is a limited set of emotions (eg,fear,
anger, etc) with specific neurophysiological and neu-
roanatomical substrates that can be considered as
“basic” and serve as the primitive building blocks from
which the other, more complex emotions are built, was
challenged as late as 1990.
11 However, Ekman has con-
vincingly argued that there is now enough evidence of
universals in expression and in physiology to suggest a
biological basis for these elementary emotions.
12
Panksepp added to these arguments by stating that
“genetically dictated brain systems that mediate affec-
tive-emotional processes do exist,even though there are
bound to be semantic ambiguities in how we speak
about these systems.”
13
The biology of fear and anxiety
Fear versus anxiety: is there a difference?
The main function of fear and anxiety is to act as a sig-
nal of danger, threat, or motivational conflict, and to
trigger appropriate adaptive responses. For some
authors,fear and anxiety are undistinguishable,whereas
others believe that they are distinct phenomena.
Ethologists define fear as a motivational state aroused
by specific stimuli that give rise to defensive behavior or
escape.
14 Animals may learn to fear situations in which
they have previously been exposed to pain or stress,and
subsequently show avoidance behavior when they reen-
counter that situation. Young animals may show an
innate fear reaction to sudden noise or disturbances in
the environment, but rapidly become habituated to
them.When they are used to a familiar environment,
then a fear of novelty may develop. Ethologists have
also made the important observation that fear is often
mixed up with other aspects of motivation.Thus,conflict
between fear and approach behavior may results in dis-
placement activities (eg,self-grooming in rats).Such dis-
placement activities may be the behavioral expression
of an anxious state, but anxiety is a concept that is
apparently not used by ethologists, perhaps because
their definition of fear does in fact include all the more
biological aspects of anxiety.
Many authors,however,have argued that differences in
their etiologies, response patterns, time courses, and
intensities seem to justify a clear distinction between
anxiety and fear.
15 Although both are alerting signals,
they appear to prepare the body for different actions.
Anxiety is a generalized response to an unknown threat
or internal conflict, whereas fear is focused on known
external danger.
15 It has been suggested that “[…] anx-
iety can only be understood by taking into account some
of its cognitive aspects, particularly because a basic
aspect of anxiety appears to be uncertainty.Also, it is
reasonable to conclude that anxiety can be distinguished
from fear in that the object of fear is ‘real’ or ‘external’
or ‘known’ or ‘objective.’ The origins of anxiety are
unclear or uncertain […].”
3 Other authors pointed out
that “[…] situations lacking in clear indications of situ-
ational contingencies or likely outcomes are associated
with considerable stress.The uncertainty regarding these
situations highlights a lack of control that contributes to
feelings of anxiety and makes coping more difficult.”
15
Barlow has described anxiety as “[…] a unique and
coherent cognitive-affective structure within our defen-
sive and motivational system […].At the heart of this
structure is a sense of uncontrollability focused largely
on possible future threats, danger, or other upcoming
potentially negative events,in contrast to fear,where the
danger is present and imminent.”
16
The fact that anxiety and fear are probably distinct emo-
tional states does not exclude some overlap in under-
lying brain and behavioral mechanisms.In fact,anxiety
may just be a more elaborate form of fear, which pro-
vides the individual with an increased capacity to adapt
and plan for the future.
16 If this is the case,we can expect
that part of the fear-mediating mechanisms elaborated
during evolution to protect the individual from an
immediate danger have been somehow “recycled” to
develop the sophisticated systems required to protect us
from more distant or virtual threats.
Defense and coping strategies
Fear or anxiety result in the expression of a range of
adaptive or defensive behaviors, which are aimed at
escaping from the source of danger or motivational con-
flict. These behaviors depend on the context and the
repertoire of the species.Active coping strategies are
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233used when escape from threat is possible,and the auto-
nomic changes associated with these active strategies are
mediated predominantly by sympathetic activation
(hypertension, tachycardia).This is the fight-or-flight
response originally described by Cannon.
17 Passive cop-
ing strategies, such as immobilization or freezing, are
usually elicited when threat is inescapable,and are usu-
ally characterized by autonomic inhibition (hypotension,
bradychardia), and a more pronounced increase in the
neuroendocrine response (activation of the hypothalamo-
pituitary-adrenal axis and increased glucocorticoid
secretion).This type of passive response was originally
described by Engel and Schmale as a conservation-with-
drawal strategy.
18The concept of alternative (active/pas-
sive) strategies itself owes much to the work of Henry
and coworkers.
19 Specific brain circuits appear to medi-
ate distinct coping reactions to different types of stres-
sors.
20,21
According to Panksepp, flight and other active coping
behaviors are unconditional responses to proximate
threat, whereas passive coping strategies, such as freez-
ing, are conditioned responses to distal stimuli predic-
tive of danger.These two strategies have distinct and
successive roles, and are modulated by the (cognitive)
apprehension of the environment and probability of suc-
cess,eg,whether or not there is a route of escape.Thus,
when an animal faces a predator, freezing is preferen-
tially activated when the source of known danger is still
far away. When danger gets closer, and the stimulus
passes through some critical “psychometric”distance,it
becomes a true unconditional stimulus and a flight pat-
tern is activated.
22
Defensive behaviors have been studied in a large num-
ber of species,
23 and it has recently been shown that
human defensive behaviors to threat scenarios are not
unlike those seen in nonhuman mammals.
24 The impor-
tance of risk assessment in making a proper decision
about the best strategy to be used in a particular context
has been emphasized.
25
It should be underlined, however, that the choice
between an active or passive defense strategy does not
entirely depend on contextual clues. Individual differ-
ences in coping styles do exist and may also influence
this choice. In a given situation, some individuals may
react actively (“proactive” style), whereas other indi-
viduals may react in a more passive way (“reactive”
style).These coping styles are characterized by consis-
tent behavioral and neuroendocrine patterns, and may
explain individual differences in vulnerability to stress-
induced diseases.
26 Differences in coping styles have also
been found between various strains of mice,
27 or between
genetically selected rat lines,
28 which suggests that they
have a genetic basis.
The capacity to cope successfully with life challenges,
whether innate or acquired,is probably a primary deter-
minant of resistance to stress-induced diseases.
29,30
Normal versus pathological anxiety
Although anxiety is a natural adaptive reaction, it can
become pathological and interfere with the ability to
cope successfully with various challenges and/or stress-
ful events,and even alter body condition (eg,formation
of gastric ulcers).
In 1926,following a major flooding disaster in Leningrad,
Pavlov reported a state of “chronic inhibition”and learn-
ing impairment in the dogs that had been successfully
trained for conditioned responses in his laboratory and
had directly experienced the flood.
31 This observation
(which may be one of the first laboratory-based accounts
of the symptoms of posttraumatic stress disorder) and
other experiments were the basis for his later studies on
“experimental neuroses”in dogs.Pavlov discovered large
differences in dogs’ individual susceptibility to psy-
chopathology,and attributed these differences to “ner-
vous types.” He described four types analogous to the
four temperaments of Hippocrates,which,according to
him,resulted from the combination of three factors:the
“strength”of the nervous system (its degree of resistance
to excitation or inhibition),the equilibrium between exci-
tation and inhibition processes,and the capacity to shift
from inhibition to excitation and vice versa.
32
Although Pavlov’s typology is outdated, it is now rec-
ognized that increased vulnerability to anxiety and its
disorders is associated with particular traits or endophe-
notypes, ie, traits that may be intermediate in the chain
of causality from genes to disease.
33These traits may be
innate or acquired during development or through expe-
rience.
Barlow has defined three interacting sets of vulnerability
factors for the development of human anxiety disorders
in humans: (i) a generalized biological vulnerability,
mainly of genetic origin;(ii) a generalized psychological
vulnerability,resulting in particular from early life expe-
riences; and (iii) a specific psychological vulnerability,
focused on particular events or circumstances.
16The lat-
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234ter set is probably implicated in the development of spe-
cific anxiety disorders (as opposed to generalized anxiety
disorders),ie, social phobia, obsessive-compulsive and
panic disorders,and specific phobias.
Increased anxiety in animal models, as a trait, can be
attributed to at least two sets of factors:(i) a genetic pre-
disposition,essentially linked to the expression of genes
that are involved in the various neurochemical mecha-
nisms underlying fear and anxiety;and (ii) the influence
of environmental factors.These environmental factors
can interact with the expression of the relevant genes
during early development and determine the functional
properties of the neural and biochemical systems involved
in coping with stressful events.They can also modulate
the learning processes that occur at a later stage, when
the individual is confronted with various life events,and
determine the capacity to cope successfully with aver-
sive or threatening situations in adulthood.
These predisposing factors, either innate or acquired,
determine individual “affective styles”
2,34 or coping strate-
gies,
26 which are thought to play an important role in vul-
nerability to psychopathology.
Animal models
Some of the neurobiological mechanisms underlying
anxiety may already be present in very simple organ-
isms,such as the snail Aplysia,which can show forms of
learning akin to anticipatory and chronic anxiety.
35
However, most animal models of anxiety are based on
the use of mammalian species, particularly rats and
mice.
36-42These models fall into two broad categories.In
the first one,animals are confronted with situations that
generate an anxious state (state anxiety models).This
state of anxiety can be either conditioned (eg, condi-
tioned fear,avoidance,and punishment-induced conflict
tests) or unconditioned (eg, aversive and ethological
conflict tests). In the second category, the models are
concerned with trait or “pathological” anxiety: genetic
manipulations (transgenic or “knockout” animals) or
selective breeding creates lines of rats or mice that per-
manently express an increased or decreased level of anx-
iety.
Functional neuroanatomy
As already suspected by Letourneau and others,emotional
experience and the associated behavioral responses are
likely to activate specific circuits in the brain.The search
for the neuroanatomical substrates of fear and anxiety
has been a successful field of research over the last
decades.
For a long time,it was assumed that emotions,including
fear and anxiety, were almost exclusively generated or
processed in a “primitive” part of the brain, ie, the lim-
bic system (“the emotional brain”).The view that emo-
tions and cognitions are separate functions of the brain
and must therefore have different underlying neu-
roanatomical substrates is probably responsible for this
simplification. As pointed out by LeDoux in a recent
review,
43 modern research with the most advanced neuro-
imaging technologies still uses this dichotomic approach
to higher brain functions as a post hoc explanation:
“When a so-called emotional task is used, and a limbic
area is activated,the activation is explained by reference
to the fact that limbic areas mediate emotions. And
when a limbic area is activated in a cognitive task, it is
often assumed that there must have been some emo-
tional undertone to the task.”However,neuroanatomi-
cal and behavioral data obtained during the last decades
clearly indicate that this dichotomy between cognitive
and emotional processes is obsolete.
The locus ceruleus and arousal
Autonomic activation and increased arousal are among
the earlier psychophysiological responses observed in a
state of fear or anxiety. Since the immediate conse-
quences of autonomic activation (eg, tachycardia) are
perhaps the most readily perceived when experiencing
a state of fear or anxiety, it has been proposed that the
ascending noradrenergic system originating from the
locus ceruleus (LC) is the core around which feelings of
anxiety are organized.
44 The LC contains a large pro-
portion of the noradrenaline (NA) cell bodies found in
the brain and it is a key brain stem region involved in
arousal  (Figure 1). It is highly responsive to
alerting/stressful stimuli. In rats, cats, and monkeys,
increased LC neuronal firing rate is associated with
alertness,selective attention to meaningful and/or novel
stimuli,and vigilance.The meaning,as well as the inten-
sity of stimuli, seems to be an important factor in LC
response. In cats, confrontation with a novel, but non-
threatening stimulus, such as a mouse, does not cause 
a specific increase in LC firing, whereas confrontation
with a threatening stimulus (eg,a dog) causes a marked
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235increase in LC firing.Thus,novelty by itself is not suffi-
cient to activate the LC/NA system,but stimuli that sig-
nal reward,as those that signal danger,may activate the
system.
45 Recent data suggest that a phasic mode of LC
activity may promote focused or selective attention,
whereas a tonic mode may produce a state of high
behavioral flexibility or scanning attentiveness.
46 Some
LC neurons project to the paraventricular nucleus (PVN)
in the hypothalamus and activate the hypothalamo-
pituitary-adrenocortical (HPA) axis,triggering or facili-
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Figure 1. A schematic view of major brain circuits involved in fear and anxiety. External auditory, visual, olfactory, or somatosensory stimuli are relayed
by the thalamus to the amygdala and cortex. The basolateral complex (BLA) of the amygdala is the input side of the system, which also
receives contextual information from the hippocampal formation (entorhinal cortex, hippocampus, and ventral subiculum). After intra-amyg-
dala processing of the emotional stimuli, the central nucleus of the amygdala (CeA), on the output side, activates the locus ceruleus (LC) and
central and peripheral noradrenaline systems (via corticotropin-releasing factor [CRF] neurons), and the hypothalamus (paraventricular nucleus
[PVN] and lateral hypothalamus [LH]). The bed nucleus of the stria terminalis (BNST, part of the “extended amygdala”) is also a control cen-
ter for the neuroendocrine system by integrating information originating from both the hippocampus and the amygdala. In addition, the
CeA directly activates various midbrain regions or nuclei responsible for different aspects of the fear/anxiety response: freezing or escape
(periaqueductal gray [PAG]), increased respiratory rate (parabrachial nucleus [PBN]), startle (caudal reticulopontine nucleus of the reticular for-
mation [RPC]), and the dorsal motor nucleus of the vagus (DMN) in the medulla, which (together with the lateral hypothalamus) is respon-
sible for the increase in heart rate and blood pressure associated with emotional events. The prefrontal cortex (PFC) processes more elabo-
rate (“cognitive”) information; it modulates the physiological, neuroendocrine, and behavioral responses (via the amygdala), and it is also
involved in the extinction of fear- and anxiety-related conditional responses. ACTH, adrenocorticotropic hormone; ANS, autonomous ner-
vous system; BP, blood pressure; GABA, γ-aminobutyric acid; Glu, glutamate; NA, noradrenaline (neurotransmitter) or nucleus ambiguus
(structure); NTS, nucleus tractus solitarius.tating the stress response associated with increased anx-
iety (Figure 1).However,although 6-hydroxydopamine
lesions of the LC in rats affect the HPA axis response to
acute stress,they do not appear to substantially affect its
response to chronic stress.
47 Noradrenergic LC neurons
also project to the amygdala (mainly to the central
nucleus of the amygdala [CeA]), the prefrontal cortex
(PFC),the bed nucleus of the stria terminalis (BNST),
the hippocampus, the periaqueductal gray (PAG), the
hypothalamus,the thalamus,and the nucleus tractus soli-
tarius (NTS),which are all areas involved in the fear/anx-
iety response (Figure 1).The LC is in turn innervated by
areas such as the amygdala (which processes fear-related
stimuli) and other areas receiving visceral stimuli relayed
by the NTS.The LC is therefore in a key position to inte-
grate both external sensory and internal visceral stimuli
and influence stress- and fear-related neuroanatomical
structures,including cortical areas.
48
The septohippocampal system and behavioral inhibition
The inhibition of ongoing behaviors is the first behav-
ioral manifestation of an anxious or fearful state.In the
1970s, Gray suggested that vulnerability to anxiety is
associated with individual differences in the activity of a
septohippocampal behavioral inhibition system (BIS).
According to Gray, this is one of the three major emo-
tional systems,which also include the behavioral approach
system (BAS) and the fight/flight system (F/FLS).
49,50The
primary function of the BIS is to compare actual with
expected stimuli. If there is a discrepancy between the
actual and expected stimuli (ie, “novelty” or “uncer-
tainty”),or if the predicted stimuli are aversive,the BIS
is activated,arousal and attention to novel environmen-
tal stimuli is increased,and ongoing behaviors are inhib-
ited. Thus, according to Gray, anticipatory anxiety
reflects a central state mediated by BIS activation,which
is elicited by threats of punishment or failure, and by
novelty or uncertainty.
51
The central role of behavioral inhibition in generating
an anxious state has also been pointed out by Laborit.
52
Anxiety is associated with the “alarm reaction,” as
defined in Selye’s original description of the stress
response (or general adaptation syndrome).
53According
to Laborit, anxiety appears when one realizes that a
proper adaptive action is not possible, ie, that there is
loss of control over the situation, and it depends on the
activation of the HPA axis.
Panksepp has argued that the activities of the ascending
NA systems and the descending BIS are not causally
related to the affective experience of fear and anxiety.
22
They may be correlated, supportive, or permissive sys-
tems for establishing brain states that participate in the
many brain readjustments accompanying fear.These sys-
tems certainly participate in the genesis of fear and anx-
iety behaviors: the NA system is involved in the initial
alarm reaction, whereas freezing promoted by septo-
hippocampal inhibition may help regulate the intensity
and duration of fear. However, according to Panksepp,
the amygdala-central gray axis plays an essential role in
creating the emotional state associated with fear and
anxiety.
22
The amygdala-hypothalamus-central gray axis and fear
In all mammalian species,there are three distinct sites in
the brain where electrical stimulation will provoke a full
fear response:the lateral and central zones of the amyg-
dala,the anterior and medial hypothalamus,and specific
areas of the PAG.A circuit coursing from the lateral and
central nuclei of the amygdala, throughout the ventral-
anterior and medial hypothalamic areas, down to the
mesencephalic PAG, may constitute the executive sys-
tem for fear,since freezing,as well as flight behavior and
the autonomic indices of fear (eg, increased heart rate
and eliminative behavior) can be evoked along the
whole trajectory of this system.
41
In rats,stepwise increases in the electrical stimulation of
the dorsolateral periaqueductal gray (dlPAG) produce
alertness,then freezing and finally escape,replicating the
sequence of natural defensive reactions when exposed
to threat. Recent data suggest that dlPAG stimulation
produces freezing independently of any contextual fear
conditioning, whereas stimulation of the ventral peri-
aqueductal gray (vPAG) appears to be critical to the
expression of conditioned fear.
54 Because electrical or
pharmacological stimulation of PAG produces a range
of fear-related responses similar to those seen in a panic
attack,this area be could be directly implicated in panic
disorder.
55,56
The amygdala and fear conditioning
The elegant studies carried out by LeDoux, based on a
simple fear conditioning paradigm in rats,have empha-
sized the primary role of the amygdala in controlling
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43,57-59 His approach is along the lines
of earlier learning/behavioral theories, eg, those of
Pavlov and Watson,
3 which emphasize the role of con-
ditioning processes in behavioral development.After a
few pairings of a threatening stimulus (eg, electric
shocks, the unconditioned stimulus [US]) with a for-
merly neutral cue (eg,a tone or visual signal,the condi-
tioned stimulus [CS]),animals will experience a state of
conditioned fear when only the cue is present.Conditioned
fear provides a critical survival-related function in the face
of threat by activating a range of protective (or defensive)
behaviors. The  neuroanatomical and neurochemical
foundations of conditioned fear,
60 based mainly on the
behavioral models of freezing and fear-potentiated star-
tle in rats
61 have been worked out in detail.In LeDoux’s
model,the amygdala and thalamic pathways are respon-
sible for the primary appraisal of threat by allowing a
rapid,automatic analysis of potentially dangerous stim-
uli. Additional brain structures, including the hip-
pocampus and cortical pathways, provide more infor-
mation on the situational context and relevant stimulus
characteristics (Figure 1).Thus, the amygdala plays a
central role by integrating rapid,direct thalamic inputs,
eg, visual information, with more detailed information,
eg,cortical integration of sensory information,originat-
ing from longer and slower neuronal pathways.
43
Activation of the amygdala by threatening stimuli then
influences cognitive processes, perception, selective
attention,and explicit memory.
The cognitive representation of fear may preferentially
involve the left amygdala, as shown by recent func-
tional magnetic resonance imaging (fMRI) studies.
62
Interestingly, a sex difference in amygdala activation
during the perception of facial affect has recently been
reported.
63 Amygdala activation (measured by fMRI)
differed for men and women depending on the valence
of the expression: happy faces produced greater right
than left amygdala activation for males, but not for
females. Both sexes showed greater left amygdala acti-
vation for fearful faces.These data suggest that the left
amygdala may be more involved in the representation
of negative affect.
The role of the various amygdala nuclei in fear condi-
tioning is now well established, notably by lesion stud-
ies.
43,59,60,64 In rats, the central and medial nuclei of the
amygdala are important in mediating conditioned aver-
sive states, but conditioned freezing may be mediated
independently.
65Thus,different types of fear-conditioned
behavior may be mediated by separate nuclei within the
amygdala.
66
The amygdala plays a pivotal role in coordinating the
behavioral, neuroendocrine, and prefrontal cortical
monoamine responses to psychological stress in rats.In
a fear-conditioning paradigm, pretraining amygdala
lesions blocked freezing behavior, ultrasonic vocaliza-
tions,adrenocortical activation,and dopaminergic meta-
bolic activation in the medial prefrontal cortex (mPFC).
Posttraining lesions blocked mPFC dopamine,serotonin
(5-hydroxytryptamine [5-HT]), and NA activation and
stress-induced freezing and defecation,and greatly atten-
uated adrenocortical activation.
67
The amygdala and positive reinforcement and attention
The role of the amygdala is not limited to fear-condi-
tioning and the processing of aversive stimuli.Studies in
rats using food-motivated associative learning indicate
that the basolateral amygdala may be involved in the
acquisition and representation of positive reinforcement
values (possibly through its connections with the ventral
striatal dopamine systems and the orbitofrontal cor-
tex).
68 Therefore, the amygdala is probably a key struc-
ture for the integration of behavior in conflicting situa-
tions, when both potentially rewarding and aversive
stimuli are present. Recent studies indicate that the
human amygdala can also process both positively and
negatively valenced stimuli.
69
Recent studies also indicate that the CeA may con-
tribute to attentional function in conditioning,by way of
its influence on basal forebrain cholinergic systems and
on the dorsolateral striatum.
68
The amygdala and social behavior and phobia
The amygdala may play an important role in regulating
social behavior.Thus,in adult macaque monkeys,selec-
tive bilateral lesions of the amygdala result in a lack of
fear response to inanimate objects and a “socially unin-
hibited”pattern of behavior.
70The amygdala may func-
tion as a protective “brake” during evaluation of a
potential threat, and it has been suggested that social
anxiety may involve a dysregulation or hyperactivity of
the amygdala evaluative process.
70 Studies in rats also
suggest that the basolateral nucleus of the amygdala
may play a crucial role in the consolidation of informa-
tion that leads to the formation of a specific phobia.
71
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Although the amygdala is clearly involved in conditioned
fear,its role in anxiety is less evident,because it is often
difficult to specify the stimuli that triggers anxiety.
72,73
Thus,lesions of the rat amygdala that suppressed fear-
elicited startle or freezing behavior did not affect mea-
sures of anxiety in the elevated plus-maze and shock-
probe–burying tests, two classic tests of anxiety for
rodents.
74 Moreover, diazepam was effective in these
tests,even in amygdala-lesioned rats,suggesting that the
anxiolytic effects of benzodiazepines are not necessar-
ily mediated by the amygdala.
75 Recent studies in pri-
mates also suggest that the amygdala is involved in medi-
ating some acute unconditioned fear responses in rhesus
monkeys, but that it is unlikely to be a key structure
regarding the dispositional behavioral and physiological
characteristics of the anxious temperament.
76
The BNST is considered to be part of the extended
amygdala.
77 It appears to be a center for the integration
of information originating from the amygdala and the
hippocampus (Figure 1), and is clearly involved in the
modulation of the neuroendocrine stress response.
78,79
Activation of the BNST,notably by corticotropin-releas-
ing factor (CRF),may be more specific for anxiety than
fear. Studies in rats with the startle reflex suggest that
explicit cues such as light, tone, or touch activate the
amygdala,which then activates hypothalamic and brain-
stem target areas involved in the expression of fear,
whereas less specific (or more complex) stimuli of longer
duration,such as exposure to a threatening environment
or intraventricular administration of CRF,may prefer-
entially involve the BNST.
73
The PFC and the control of emotional responses
The primary roles of the PFC appear to be the analysis
of complex stimuli or situations and the control of emo-
tional responses.
In a revised version of his original BIS model,Gray pos-
tulated that the PFC may modulate septohippocampal
activity, and that lesions to this area would impair the
processing of vital information for the subicular com-
parator, and subsequently affect behavioral inhibition
and anticipatory anxiety.
51 He also suggested that the
role of cortical structures in anxiety was probably more
prominent in primates,based on the increased anatom-
ical relationship between the septohippocampal system
and the prefrontal and cingulate cortices observed in
monkeys. Recent studies in humans and primates have
largely confirmed Gray’s hypothesis,and it is now clear
that the various subdivisions of the human PFC (dorso-
lateral, ventromedial, and orbital sectors) have specific
roles in representing affect in the absence of immediate
rewards or punishments and in controlling emotional
responses.
80,81 There appear to be important functional
differences between the left and right sides within each
of these sectors. Earlier studies on patients with unilat-
eral brain lesions have already emphasized the role of
cerebral lateralization in emotional information pro-
cessing.
82 More recently, brain electrical activity mea-
sures and positron emission tomography (PET) studies
have indicated that negative affect and anxiety are asso-
ciated with increased activation of the right PFC;more-
over, individual differences in baseline levels of asym-
metric activation in the PFC may be associated with
individual differences in affective styles and vulnerabil-
ity to mood and anxiety disorders.
81
There is also increasing evidence that the PFC plays an
important role in controlling anxiety and the associated
stress response in rats, and that cerebral laterality is an
important feature of the PFC system.Thus, in a recent
study right, but not left, lesions of the ventral medial
PFC were shown to have anxiolytic effects, and were
also more effective in suppressing the neuroendocrine
and autonomic stress response.
83
Neurochemical correlates
A large number of neurotransmitters, peptides, hor-
mones,and other neuromodulators have been implicated
in fear and anxiety.We shall only discuss a few repre-
sentative examples.
The noradrenergic system
Several preclinical studies have shown that stress and
anxiety cause a marked increase in NA release in several
rat brain regions,including the hypothalamus,the amyg-
dala,and the LC.
84
In agreement with these data, yohimbine, an α2-adren-
ergic receptor antagonist that increases NA release in
the brain, has been shown to have anxiogenic effects in
rats.
84 However,pharmacological experiments involving
the administration of various α2A-receptor agonists or
antagonists in several animal models of anxiety are
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monoaminergic receptors.
85 In a recent study, local
administration into the LC region of an antisense
oligodeoxynucleotide (AS-ODN) corresponding to the
α2A-receptor mRNA was shown to have an anxiolytic
effect,
85 but another study has also shown that genetic
knockout of the α2A-receptor in mice resulted in a more
anxious phenotype than that of the corresponding
C57BL/6 wild type.
86
The role of the various NA receptor subtypes in medi-
ating NA action on fear- and anxiety-related behaviors
is therefore not settled. The precise location of the
receptor subtypes within the complex circuitry mediat-
ing fear and anxiety responses is probably critical.
The serotonergic system
Data on the role of 5-HT in anxiety are conflicting:there
is no agreement whether 5-HT enhances or,conversely,
decreases anxiety. Thus, a 5-HT2C agonist such as m-
chlorophenylpiperazine (mCPP) has anxiogenic effects
in humans and may induce panic attacks, obsessions,
and other neuropsychiatric symptoms,whereas selective 
5-HT reuptake inhibitors (SSRIs) and 5-HT1A or 5-HT3
receptor–selective drugs can have antianxiety effects in
certain anxiety disorders and animal models.
87
On the basis of data obtained from animal models,
Graeff et al have proposed a “dual 5-HT fear hypothe-
sis”postulating that 5-HT may enhance conditioned fear
in the amygdala,while inhibiting innate fear in the dor-
sal PAG.
88The ascending 5-HT pathway originating from
the dorsal raphe nucleus (DRN) and innervating the
amygdala and frontal cortex facilitates conditioned fear,
while the DRN-periventricular pathway innervating the
periventricular and PAG matter inhibits inborn fight/flight
reactions to impending danger,pain,or asphyxia.
89The
same authors have also proposed that the pathway con-
necting the median raphe nucleus (MRN) to the hip-
pocampus may promote resistance to chronic,unavoid-
able stress by facilitating hippocampal 5-HT1A trans-
mission.
89
These results demonstrate that it is not possible to con-
clude about an “anxiogenic”or “anxiolytic”role for 5-HT
(or,for that matter,of any other neurotransmitter,pep-
tide,or hormone) without considering its site of action in
the brain and/or the receptor subtype implicated.
Indirect evidence that the anxiolytic action of 5-HT is
mediated by the 5-HT1A receptor has been obtained by
three independent groups who have reported an “anx-
ious” phenotype in 5-HT1A receptor knockout mice
compared with corresponding wild-type mice, using
three different genetic backgrounds.
90 Depending on this
background, the null mutation may be associated with
changes in GABAergic transmission.
91 More recently,it
has been shown that 5-HT1A receptor knockouts display
an “anxious-like”phenotype not only at the behavioral,
but also at the autonomic response level.
92This seems to
provide a strong argument in favor of an important role
of 5-HT1A receptor gene expression for anxiety-related
behaviors. In contrast, 5-HT1B receptor knockout mice
were found to be more aggressive, more reactive, and
less anxious than their wild-type counterparts, suggest-
ing that this receptor may also modulate 5-HT action on
defense mechanisms.
93 Serotonin transporter (5-HTT)
knockout mice (5-HTT-/-) have also been produced,and
shown to display elevated anxiety in various behavioral
tests, and an increased stress response (adenocorti-
cotropic hormone [ACTH] secretion) following a mild
stress,which was also observed to a lesser degree in the
5-HTT+/- heterozygotes.
94
The GABAergic system
γ-Aminobutyric acid (GABA) is the most abundant
inhibitory neurotransmitter in the brain.The GABAA-
benzodiazepine receptor is an important target for sev-
eral anxiolytic drugs and may therefore play an impor-
tant role in anxiety-related disorders.
95 Several GABAA
receptor subtypes have been described.
96,97
The diazepam-sensitive α2-GABAA subtype appears to
be specifically involved in anxiolysis.
96 This subtype is
largely expressed in the hippocampus,the amygdala,and
the striatum.
98 Two mouse lines were generated with a
knockin point mutation on the α2 or α3 subunit, which
rendered them insensitive to diazepam.The anxiolytic
action of diazepam was suppressed in mice with the
α2(H101R) point mutation, but not in those with the
α3(H126R) point mutation.
99
Heterozygous γ2-knockout mice (γ2+/-) have been gen-
erated (the homozygous mutation is not viable).
98These
mice show enhanced reactivity to natural aversive stim-
uli,increased passive avoidance responses,and a deficit
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in ambiguous cue discrimination.
100They have been pro-
posed as a model for trait anxiety characterized by harm
avoidance behavior and explicit memory bias for threat
cues (enhanced sensitivity to negative associations).
In contrast to the anxiolytic action of benzodiazepine-
like compounds, inverse agonists of the GABA/benzo-
diazepine receptor such as the β-carbolines are well
known to be anxiogenic. Recently, intrahippocampal
injections of a novel inverse agonist (RY024) have been
shown to produce a fear response (freezing) and to
interfere with fear-conditioning in rats.
101
The neurosteroids
The neurosteroids are a novel, interesting class of neu-
romodulators synthesized in the brain directly from cho-
lesterol.
102They appear to act essentially via an allosteric
modulation of the GABAA receptor, although other
receptors may also be involved.
102,103 As early as 1987,
Majewska suggested that neurosteroids could play an
important role in mood regulation.
104 Several studies
have shown that positive allosteric modulators (which
potentiate GABA action), such as progesterone and
allopregnanolone,have anxiolytic effects in various ani-
mal models.
103 Neurosteroid synthesis is regulated by a
peripheral benzodiazepine receptor (PBR) located on
the outer mitochondrial membrane,
105 and part of the
anxiolytic effects of benzodiazepine could in fact involve
increased neurosteroid synthesis. Compounds with a
selective affinity for the PBR, such as FGIN-1-27, have
shown an anxiolytic action in rats.
106 Neurosteroids are
currently attracting a lot of interest because of their
potential role as natural,endogenous anxiolytics.
Hormones of the HPA axis
Hormones of the HPA axis, such as cortisol, or cortico-
sterone (in rodents),ACTH,and CRF are usually increased
in a state of fear and anxiety.They also appear to modulate
the response to threatening events.
Corticotropin-releasing factor
Intracerebral administration of CRF has been shown to
elicit anxious-like behavior in rats.
107 More recent pre-
clinical studies suggest that CRF and its receptors play
a pivotal,integrative role in the stress response and anx-
iety-related behaviors.
108,109There are two major CRF sys-
tems in the brain:the neuroendocrine system in the PVN,
and another system with CRF cells located in the amyg-
dala (CeA) and BNST, which would be more directly
related to the physiological and behavioral responses
associated with fear and anxiety.Whereas glucocorticoids
restrain CRF production in the PVN (the neuroendo-
crine negative feedback loop), they appear to increase
CRF expression in the amygdala and BNST, thus pro-
moting fear- and anxiety-related behavior.
110 CRF neu-
rons originating from the amygdala project onto the LC
(Figure 1) and contribute to increased arousal in fear
and anxiety states.
111 In a rat model,a full postsynaptic
CRF agonist,CRF(1-41),increased arousal at low dosage
and had an anxiogenic action at higher doses.
112This sug-
gests that progressively increasing levels of CRF in the
brain may ensure the transition from the initial state of
increased arousal to the anxious state of expectancy in
stressful situations.
Transgenic mice overexpressing CRF show a behavioral
and neuroendocrine profile consistent with an increased
level of stress and anxiety, including elevated plasma
ACTH and corticosterone levels, and generally exhibit
the same behavioral changes as those observed in mice
following exogenous CRF administration.
113-115 Recent
data indicate a desensitization of postsynaptic, but not
presynaptic 5-HT1A receptors in mice overproducing
CRF.
116 Another line of transgenic mice overexpressing
CRF (CRH-OE(2122)) has shown a reduced startle
reactivity,habituation,and prepulse inhibition.
117
Deletion of the CRF gene (CRF-KO mice) results in
chronic glucocorticoid insufficiency,and this may cause
severe developmental problems.
114,118 Despite an impaired
stress-induced activation of the HPA axis,the behavioral
stress responses do not appear to be markedly affected
in CRF-deficient mice,suggesting that other CRF-like
molecules may be implicated in the behavioral effects
mediated by CRF receptors.
114,118-120 CRF-KO mice also
display normal startle- and fear-conditioned responses.
120
CRF receptors and CRF binding protein
Deletion of the genes coding for CRF receptors 1 (CRF-
R1) or 2 (CRF-R2) have more profound behavioral
effects.
114,115,121-124 CRF-R1-deficient mice display decreased
anxiety and an impaired stress response,
125 whereas dele-
tion of the CRF-R2 gene has the reverse effect in males
(but not in females): anxiety is increased in Crhr2-/-.
126
These data suggest that CRF-R1 mediates the anxio-genic effects of CRF,whereas CRF-R2 may be involved
in anxiolysis. Recently, mice deficient in both CRF-R1
and CRF-R2 receptors have been generated.
127 These
double mutants display altered anxiety-related behavior
and an impaired HPA axis response to stress.
Interestingly,the effects on anxiety are again sex-depen-
dent: females show a decreased anxiety similar to that
observed in Crhr1-/- mutants,whereas the genotype has
no effect on male anxiety-related behaviors.These stud-
ies have also demonstrated a novel role of the mother’s
genotype on the development of pup anxiety:pups born
to a heterozygous or mutant mother display significantly
more anxiety,regardless of that pup’s genotype.
127
The CRF binding protein (CRF-BP) may play an impor-
tant modulatory role in CRF action.
128 Interesting data
consistent with a modulatory action of CRF-BP have
recently been obtained with transgenic and knockout
models: transgenic males overexpressing CRF-BP tend
to show less anxiety, whereas the behavior of CRF-BP-
deficient mice was consistent with increased anxiety.
129
Corticosteroids
Corticosteroids effects on anxiety-related behaviors may
be mediated by both genomic and nongenomic mecha-
nisms (control of neuronal excitability).Hippocampal cor-
ticosteroid receptors play an important role in the termi-
nation of the acute stress response.
130 Studies with a model
of posttraumatic stress disorder in rats suggest an alter-
ation of the mineralocorticoid receptor (MR) vs gluco-
corticoid receptor (GR) balance, as measured by the
expression of mRNA levels in the hippocampus,during
the recovery phase following acute stress: the MR/GR
ratio was decreased,but only in animals with an enhanced
fast feedback.
131 Recent data also suggest that,at low cir-
culating levels,corticosteroids exert a permissive action
(via MRs) on acute freezing behavior and other acute
fear-related behaviors.At higher levels,corticosteroids
enhance acquisition,conditioning,and consolidation of an
inescapable stressful experience, as well as processes
underlying fear potentiation,via GR-dependent mecha-
nisms.
132 Mice with targeted mutation of the MR and GR
receptors display altered anxiety-related behaviors.
133
Other peptides, neurotransmitters, and hormones
Several peptides, such as cholecystokinin (CCK), neu-
ropeptide Y (NPY), tachykinins (substance P, neuro-
kinins A and B), and natriuretic peptides (atrial natri-
uretic peptide or C-type natriuretic peptide) may play
important roles in fear- and anxiety-related behaviors.
134
CCK may be particularly relevant for panic disor-
ders,
135,136 and may influence cognitive processes.
137
Excitatory amino acids (EAA), such as glutamate, are
also important.In rats,microinjections of EAA into the
dorsolateral PAG induce a flight reaction. Part of the
effects mediated by N-methyl-D-aspartate (NMDA)
receptors may involve nitric oxide (NO). Nitric oxide
synthase (NOS) inhibitors injected in the dorsolateral
PAG have been shown to have anxiolytic effects, and
psychological stress (restraint) induced an increased
expression of neuronal NOS in the same area and in
other areas related to defense mechanisms, suggesting
that NO may participate in these defensive responses.
138
We have also shown that anticipatory anxiety can lead
to a decreased secretion of luteinizing hormone (LH)
and testosterone in young,healthy male subjects.
139
Genetic and environmental factors
Individual differences in sensitivity to threat or stress,
and particular coping or affective styles appear to be
critical predisposing factors for anxiety-related disorders.
Genetic and environmental factors have been implicated,
and how these factors interact during development is
one of the major questions addressed by recent clinical
and fundamental research.
Genetic determinants 
A genetic basis for anxiety-related behaviors is now
clearly established,notably through several family,twin,
and adoption studies.
In mice,targeted gene mutations have shown that mod-
ifying the expression of particular genes can have a pro-
found effect on anxiety-related behavioral pheno-
types.
39,140 Some examples were mentioned in the
preceding section.
Natural variations in trait anxiety, or emotionality, in
inbred rat and mouse strains are being extensively stud-
ied.
27,39,141-146 Some of these strains show differences in sen-
sitivity to anxiolytic agents such as diazepam.
147,148 Cross-
breeding of inbred rodents strains has shown the
quantitative nature of many anxiety-related traits.
149,150
The quantitative trait locus (QTL) method is based on
a comparison between the allelic frequency of DNA
State of the art
242markers and quantitative behavioral traits.
146,150 It has
been used to assess gene effects on fear,emotionality,and
anxiety-related behaviors in mice from various genetic
backgrounds.
140,151 Loci on mouse chromosomes 1,4,and
15 were found to operate in four tests of anxiety,whereas
loci on chromosomes 7,12,14,18,and X influenced only
a subset of behavioral measures.
152 A QTL influencing
anxiety has also been found recently on rat chromosome
5.
153
Selective breeding of mice and rats has also been used
to create lines that show extreme behavioral character-
istics within the range of the normal population.
140
Various selection criteria can be used,which may not be
directly related to anxiety.Thus,rat lines initially selected
for their good versus poor performance in two-way,
active avoidance were subsequently shown to differ in
trait anxiety, or emotionality. For instance, the Roman
high- (RHA/Verh) and low- (RLA/Verh) avoidance rat
lines display clear differences in emotionality and anxi-
ety-related behaviors.
28,154The more anxious (RLA/Verh)
rats display increased neuroendocrine and autonomic
reactivity to mild stressors.
28,155,156 Differences in vaso-
pressin, oxytocin, and CRF action at the level of the
amygdala,
156,157 dopaminergic and GABAergic neuro-
transmission,
158 basal vasopressin mRNA expression in
the hypothalamic PVN,
159 and 5-HTT levels in the frontal
cortex and hippocampus
160 have been reported.We have
shown an increased capacity (enzymatic activities) for
the production of progesterone-derived,anxiolytic neu-
rosteroids in the frontal cortex and BNST of RHA/Verh
rats, which may explain in part the differences in emo-
tional reactivity of these two lines.
28 These two rat lines
also differ in their respective coping styles and response
to novelty,
154,155 and this model may therefore prove use-
ful for studying the interaction between anxiety and
defense mechanisms.
Recently, two Wistar rat lines have been selected and
bred for high anxiety-related behavior (HAB) or low
anxiety-related behavior (LAB) on the elevated plus-
maze, a classical test for anxiety in rodents.
149 The neu-
roendocrine, physiological, and behavioral characteris-
tics of these two lines are being extensively studied,and
show some similarities,but also differences,as compared
to the Roman rat lines.
161-167 Further comparison between
lines such as the RHA/RLA and HAB/LAB rats,which
have been selected on different behavioral criteria
(avoidance versus anxiety in the elevated plus-maze
test),but show a similar,anxiety-related behavioral phe-
notype,may be extremely fruitful to delineate brain mech-
anisms underlying specific aspects of anxiety disorders.
Environmental influences
The role of environmental influences in the etiology of
anxiety is also well established.
15 Early adverse experi-
ence is a major developmental risk factor for psy-
chopathology.
168-170
Prenatal stress in animal models has been shown to per-
manently alter brain morphology,anxiety-related behav-
ior, coping, and regulation of the HPA axis in adult-
hood.
171 Naturally occurring variations in maternal care
can also alter the regulation of genes controlling the
behavioral and neuroendocrine responses to stress, as
well as hippocampal synaptic development.These effects
are responsible for stable,individual differences in stress
reactivity,as well as the maternal behavior of female off-
spring.
172They could constitute the basis of a nongenetic
mechanism for the transmission of individual differences
in stress reactivity and coping styles across generations.
In 1958, Levine reported that rats handled for the first
21 days of life exhibit reduced fearfulness compared
with nonhandled controls. Since then, several studies
have shown the beneficial effects of neonatal handling
and a progressive habituation to stress on adults’ stress
responses and anxiety-related behaviors.Neonatal hand-
ling can even reverse the behavioral abnormalities
induced by prenatal stress.
173 These effects appear to be
mediated essentially by the CRF/HPA axis system,
174,175
although the serotonergic and catecholaminergic sys-
tems could be also involved.
176,177A study has shown that
neonatal handling increases the expression of the
peripheral benzodiazepine receptor (PBR),which has
been implicated in the synthesis of endogenous,natural
anxiolytic agents such as the neurosteroids,in rat adren-
als, kidney, and gonads.
178 It is likely that increased
adrenal production of naturally anxiolytic compounds
such as allopregnanolone contributed to the decrease in
anxiety reported in this study.
Sex differences in the effects of neonatal handling have
been recently reported:neonatal handling may provide
males with a greater capacity to actively face chronic
stressors.
179 Recent data indicate that neonatal handling
can also affect memory processes involved in contextual
fear conditioning.
180
In the Roman rat lines,neonatal handling has been shown
to alter the behavioral phenotype of the more anxious
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same way as their nonhandled,hypoemotional RHA/Verh
counterparts.Females were found to be more sensitive
than males to the positive influences of early stimula-
tion.
181 The effects of neonatal handling on RLA/Verh
rats were not limited to behavioral stress responses and
coping behaviors,but were accompanied by a concomi-
tant decrease in stress-induced ACTH, corticosterone,
and prolactin release,indicating that the neurochemical
substrates underlying these responses were also perma-
nently affected by early experience.
182,183
This and other examples indicate that the developmen-
tal processes that determine individual sensitivity to
stressors,or emotionality,and coping behaviors involve
complex interactions between genetic and environmen-
tal factors, and that anxiety-related phenotypes cannot
be predicted on the sole basis of a genetic predisposition
or early adverse experience.
Conclusions
The biological bases of fear and anxiety are now recog-
nized, and the major brain structures and neuronal cir-
cuits involved in emotional information processing and
behavior are delineated. Emotional and cognitive
processes cannot be dissociated,even when considering
such a basic emotion as fear.The cognitive apprehension
of events and situations is critically involved in emo-
tional experiences and also influences coping strategies
or defense mechanisms.This is reflected in the important
role now attributed to the PFC in controlling emotional
behavior in humans and animals.
Molecular biology techniques,such as those used to cre-
ate transgenic and knockout mice,have been successful
in exploring the role of various neurotransmitters, pep-
tides, hormones, and their receptors in mediating the
appraisal of stressful stimuli, information processing
through the various neuronal circuits, and the physio-
logical responses and behaviors associated with fear and
anxiety.
It is now clear that individual differences in affective or
coping styles, which are also observed in nonhuman
species,are directly associated with vulnerability to psy-
chopathology. Studying these individual differences,
including sex-related differences,in humans and in ani-
mal models will give interesting clues about the brain
mechanisms of emotional behavior.
Finally,the study of genetic predisposition and environ-
mental influences, particularly during early develop-
ment, in determining vulnerability traits and anxiety-
prone endophenotypes is certainly becoming one of the
major, and perhaps most promising, domains of con-
temporary research with respect to our understanding
of the etiology of anxiety and mood disorders. ❏
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La biología de las conductas relacionadas
con el miedo y la ansiedad
La ansiedad es una condición psicológica, fisioló-
gica y conductual que se induce en los animales y
en el hombre por una amenaza al bienestar o a la
sobrevivencia, sea presente o potencial. Se carac-
teriza por un aumento del alerta, expectación, acti-
vación autonómica y endocrina, y patrones con-
ductuales específicos. La función de estos cambios
es facilitar la adaptación ante una situación adversa
o inesperada. La ansiedad patológica interfiere con
la capacidad para adaptarse exitosamente a los
desafíos de la vida. La vulnerabilidad a la psicopa-
tología parece ser una consecuencia de factores
predisponentes (o rasgos) los cuales se deben a
numerosas interacciones entre los genes y el
ambiente durante el desarrollo (especialmente
durante el período perinatal) y a lo largo del curso
de la vida (acontecimientos vitales). En esta revisión
se examinará la biología del miedo y la ansiedad
desde aproximaciones sistémicas (relaciones cere-
bro-conducta, circuitos neuronales y neuroanato-
mía funcional) y moleculares/celulares (neurotrans-
misores, hormonas y otros factores bioquímicos)
poniendo especial atención a los modelos anima-
les. Estos modelos han constituido un medio para
establecer los correlatos biológicos del miedo y la
ansiedad; sin embargo, el reciente desarrollo de
métodos de investigación no invasores en huma-
nos, como las diversas técnicas de neuroimágenes,
ciertamente abre nuevas vías de investigación en
este campo. Nuestro conocimiento actual de las
bases biológicas del miedo y la ansiedad ya es nota-
ble y se puede esperar que a futuro se progrese
hacia modelos o teorías que integren contribucio-
nes desde las ciencias médicas, biológicas y psico-
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